Patrick A. Gladding,Marja-Liisa Dahl,Mark W. Webster
申请号：
US16408422
公开号：
US20200138795A1
申请日:
2019.05.09
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention provides methods for predicting or determining a subject's response to an antiplatelet agent, and methods for determining a subject's suitability to a treatment regime or intervention for a disease associated with platelet aggregation, using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's response to an antiplatelet agent. Nucleotide probes and primers, kits, and microarrays suitable for such assessment are also provided
